Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2016 Update

Date: June 8, 2016
Pages: 42
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NF5CDBE4734EN
Leaflet:

Download PDF Leaflet

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2016 Update
Summary

Nanosphere, Inc. (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Its verigene system is used to identify and treat the bacteria and viruses. Nanosphere offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company’s cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Nanosphere, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Nanosphere, Inc. Company Snapshot
Nanosphere, Inc. Company Overview
Nanosphere, Inc. Pipeline Products and Clinical Trials Overview
Nanosphere, Inc. – Pipeline Analysis Overview
Key Facts
Nanosphere, Inc. - Major Products and Services
Nanosphere, Inc. Pipeline Products by Development Stage
Nanosphere, Inc. Pipeline Products Overview
Next Generation Fully Automated Analyser
Next Generation Fully Automated Analyser Product Overview
Next Generation Verigene Flex System
Next Generation Verigene Flex System Product Overview
Processor SP - Multiplex Blood Culture ID Test
Processor SP - Multiplex Blood Culture ID Test Product Overview
Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease
Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease Product Overview
Ultra-Sensitive Assay - Alzheimer’s Disease
Ultra-Sensitive Assay - Alzheimer’s Disease Product Overview
Ultra-Sensitive Assay - Bladder Cancer
Ultra-Sensitive Assay - Bladder Cancer Product Overview
Ultra-Sensitive Assay - Colon Cancer
Ultra-Sensitive Assay - Colon Cancer Product Overview
Ultra-Sensitive Assay - Kidney Cancer
Ultra-Sensitive Assay - Kidney Cancer Product Overview
Ultra-Sensitive Assay - Non-Cancer Kidney Diseases
Ultra-Sensitive Assay - Non-Cancer Kidney Diseases Product Overview
Ultra-Sensitive Assay - Ovarian Cancer
Ultra-Sensitive Assay - Ovarian Cancer Product Overview
Ultra-Sensitive Protein Assay - Autoimmune Disease
Ultra-Sensitive Protein Assay - Autoimmune Disease Product Overview
Ultra-Sensitive Protein Assay - Cardiac Troponin I
Ultra-Sensitive Protein Assay - Cardiac Troponin I Product Overview
Ultra-Sensitive Protein Assay - Chronic Heart Failure
Ultra-Sensitive Protein Assay - Chronic Heart Failure Product Overview
Ultra-Sensitive Protein Assay - Respiratory Disease
Ultra-Sensitive Protein Assay - Respiratory Disease Product Overview
Ultra-Sensitive Protein Assay - Sepsis
Ultra-Sensitive Protein Assay - Sepsis Product Overview
Verigene - HFE Nucleic Acid Test
Verigene - HFE Nucleic Acid Test Product Overview
Verigene Blood Culture - Fungal Test (BC-F)
Verigene Blood Culture - Fungal Test (BC-F) Product Overview
Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test
Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test Product Overview
Verigene Yeast Blood Culture Test (BC-Y)
Verigene Yeast Blood Culture Test (BC-Y) Product Overview
Nanosphere, Inc. - Key Competitors
Nanosphere, Inc. - Key Employees
Nanosphere, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Nanosphere, Inc., Recent Developments
May 16, 2016: Nanosphere Announces First Quarter Results
Mar 03, 2016: Nanosphere’s Verigene BC-GP Decreases Patient Length of Stay
Feb 24, 2016: Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress
Jan 06, 2016: Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results
Dec 23, 2015: Verigene BC-GN Positioned to Provide Rapid Diagnosis of “Phantom Menace” Superbug
Nov 09, 2015: Nanosphere Announces Record Q3 2015 Results
Sep 22, 2015: Nanosphere Presents clinical data On Verigene Gram-Negative Blood Culture Test at ICAAC 2015
Sep 22, 2015: Nanosphere Presents clinical data On Verigene Gram-Positive Blood Culture Test for rapid sepsis diagnostics at ICAAC 2015
Sep 08, 2015: Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test
Aug 10, 2015: Nanosphere Announces Record Q2 2015 Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Nanosphere, Inc. Pipeline Products and Clinical Trials Overview
Nanosphere, Inc. Pipeline Products by Equipment Type
Nanosphere, Inc. Pipeline Products by Indication
Nanosphere, Inc., Key Facts
Nanosphere, Inc., Major Products and Services
Nanosphere, Inc. Number of Pipeline Products by Development Stage
Nanosphere, Inc. Pipeline Products Summary by Development Stage
Next Generation Fully Automated Analyser - Product Status
Next Generation Fully Automated Analyser - Product Description
Next Generation Verigene Flex System - Product Status
Next Generation Verigene Flex System - Product Description
Processor SP - Multiplex Blood Culture ID Test - Product Status
Processor SP - Multiplex Blood Culture ID Test - Product Description
Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease - Product Status
Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease - Product Description
Ultra-Sensitive Assay - Alzheimer’s Disease - Product Status
Ultra-Sensitive Assay - Alzheimer’s Disease - Product Description
Ultra-Sensitive Assay - Bladder Cancer - Product Status
Ultra-Sensitive Assay - Bladder Cancer - Product Description
Ultra-Sensitive Assay - Colon Cancer - Product Status
Ultra-Sensitive Assay - Colon Cancer - Product Description
Ultra-Sensitive Assay - Kidney Cancer - Product Status
Ultra-Sensitive Assay - Kidney Cancer - Product Description
Ultra-Sensitive Assay - Non-Cancer Kidney Diseases - Product Status
Ultra-Sensitive Assay - Non-Cancer Kidney Diseases - Product Description
Ultra-Sensitive Assay - Ovarian Cancer - Product Status
Ultra-Sensitive Assay - Ovarian Cancer - Product Description
Ultra-Sensitive Protein Assay - Autoimmune Disease - Product Status
Ultra-Sensitive Protein Assay - Autoimmune Disease - Product Description
Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Status
Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Description
Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Status
Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Description
Ultra-Sensitive Protein Assay - Respiratory Disease - Product Status
Ultra-Sensitive Protein Assay - Respiratory Disease - Product Description
Ultra-Sensitive Protein Assay - Sepsis - Product Status
Ultra-Sensitive Protein Assay - Sepsis - Product Description
Verigene - HFE Nucleic Acid Test - Product Status
Verigene - HFE Nucleic Acid Test - Product Description
Verigene Blood Culture - Fungal Test (BC-F) - Product Status
Verigene Blood Culture - Fungal Test (BC-F) - Product Description
Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test - Product Status
Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test - Product Description
Verigene Yeast Blood Culture Test (BC-Y) - Product Status
Verigene Yeast Blood Culture Test (BC-Y) - Product Description
Nanosphere, Inc., Key Employees

LIST OF FIGURES

Nanosphere, Inc. Pipeline Products by Equipment Type
Nanosphere, Inc. Pipeline Products by Development Stage

COMPANIES MENTIONED

Myriad Genetics, Inc.
GenMark Diagnostics, Inc.
Meridian Bioscience, Inc.
Skip to top


Ask Your Question

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: